Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leishmania infection and virulence.

G Matlashewski1

  • 1Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada. greg_matlashewski@maclan.mcgill.ca

Medical Microbiology and Immunology
|January 5, 2002
PubMed
Summary

Leishmaniasis, a major infectious disease, is better understood through new research identifying key virulence factors. Scientists are pinpointing molecules like lipophosphoglycan and gp63 essential for causing infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol.

BMJ open·2016
Same author

Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2005
Same author

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2001
Same author

Clearance of infection with Mycobacterium bovis BCG in mice is enhanced by treatment with S28463 (R-848), and its efficiency depends on expression of wild-type Nramp1 (resistance allele).

Antimicrobial agents and chemotherapy·2001
Same author

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections.

Vaccine·2001
Same author

Control of interferon signaling in human papillomavirus infection.

Cytokine & growth factor reviews·2001

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Molecular Biology

Background:

  • Leishmaniasis is a significant global health challenge, particularly in developing nations.
  • Understanding the parasite's life cycle and infection mechanisms is crucial for control.

Purpose of the Study:

  • To identify and discuss critical virulence factors of Leishmania parasites.
  • To highlight the role of specific molecules in the pathogenesis of leishmaniasis.

Main Methods:

  • Utilized advanced biochemical, genomics, and reverse genetics techniques.
  • Employed effective culture conditions for various life cycle stages of the parasite.
  • Analyzed the function of identified virulence factors in the infection process.

Main Results:

  • Several key virulence factors were identified and characterized.
  • Lipophosphoglycan (LPG), A2 proteins, cysteine proteinases, and gp63 were confirmed as important for infection.
  • These factors play distinct roles in the parasite's survival and host invasion.

Conclusions:

  • Effective culture methods and modern molecular tools have enabled significant progress in understanding leishmaniasis.
  • Targeting identified virulence factors like gp63 and cysteine proteinases offers potential therapeutic strategies.
  • Further research into these factors will advance the development of new treatments and vaccines.

Related Experiment Videos